Jiangsu Gdk Biological Technology Co., Ltd (SHA:688670)
China · Delayed Price · Currency is CNY 15.93
-0.38 (-2.33%)
Sep 2, 2026, 3:00 PM CST
Jiangsu Gdk Biological Technology Company Description
Jiangsu Gdk Biological Technology Co., Ltd engages in the research, development, production, and sale of human vaccines.
It offers quadrivalent influenza virus split vaccines. The company human vaccine products are used for the prevention of various infectious diseases, including influenza, rabies, chickenpox, shingles, and pneumonia.
Jiangsu Gdk Biological Technology Co., Ltd was founded in 2008 and is based in Taizhou, China.
Jiangsu Gdk Biological Technology Co., Ltd
| Country | China |
| Founded | 2008 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 390 |
| CEO | Liangbin Zhang |
Contact Details
Address: No. 12 Yujin Road Taizhou, 225300 China | |
| Phone | 86 523 8620 5860 |
| Website | gdkbio.com |
Stock Details
| Ticker Symbol | 688670 |
| Exchange | Shanghai Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| ISIN Number | CNE100004NR4 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Qiang Huang | Financial Director and Accounting Supevisor |
| Jin Zhou | Secretary to the Board |